Paroxetine and fluconazole therapy for HIV-associated neurocognitive impairment: results from a double-blind, placebo-controlled trial

Erratum: HIV-associated neurocognitive disorder — pathogenesis and prospects for treatment

(2016) Deanna Saylor et al.   Nature Reviews Neurology

Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease

(2014) Kelly A. Meulendyke et al.   JOURNAL OF NEUROVIROLOGY

Interaction of Paroxetine with Mitochondrial Proteins Mediates Neuroprotection

(2014) Joseph P. Steiner et al.   Neurotherapeutics

A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder

(2013) Liana S. Rosenthal et al.   JOURNAL OF NEUROVIROLOGY

A comparison of performance-based measures of function in HIV-associated neurocognitive disorders

(2011) Nishiena S. Gandhi et al.   JOURNAL OF NEUROVIROLOGY

Minocycline treatment for HIV-associated cognitive impairment: Results from a randomized trial

(2011) N. Sacktor et al.   NEUROLOGY

Selegiline and oxidative stress in HIV-associated cognitive impairment

(2009) G. Schifitto et al.   NEUROLOGY